• Corynoline Induces Mitochondrial Apoptosis in Osteosarcoma v

  2026-07-07

  The referenced study demonstrates that corynoline, a natural isoquinoline alkaloid, suppresses osteosarcoma cell proliferation by inducing G2/M cell cycle arrest and promoting mitochondrial apoptosis through Src/JNK signaling. These mechanistic insights not only highlight corynoline’s therapeutic potential, but also underscore the importance of precise apoptosis detection methods in osteosarcoma research.

• Peroxiredoxin-Induced Autophagy in E. histolytica Infection:

  2026-07-07

  This study uncovers how Entamoeba histolytica peroxiredoxin (Prx) triggers autophagy in host macrophages via the TLR4-TRIF pathway, contributing to parasite pathogenicity. These findings reveal a novel host-pathogen interaction, informing future research on innate immunity and autophagy modulation.

• Dorsomorphin (Compound C): Strategic Leverage in AMPK and BM

  2026-07-06

  This article provides translational researchers with a mechanistic and strategic guide to deploying Dorsomorphin (Compound C) for precise modulation of AMPK and BMP signaling. Bridging new evidence from metabolic disease models and highlighting protocol best practices, it positions APExBIO’s Dorsomorphin as a keystone inhibitor for advancing autophagy, differentiation, and iron metabolism studies.

• Phase Separation in Plant Virus Movement: Mechanisms and Ins

  2026-07-06

  This study elucidates how the plant virus movement protein p26 undergoes phase separation with cellular factors, revealing the molecular determinants that enable virus-host interactions and systemic viral spread. The findings highlight the roles of electrostatic interactions in p26 partitioning, nucleolar trafficking, and antiviral responses, offering a mechanistic framework for studying RNA-protein assemblies in plant pathology.

• Marein Restores Chemosensitivity via ABCG2 Inhibition in Can

  2026-07-05

  This study identifies marein, a natural chalcone derivative, as a potent competitive inhibitor of the ABCG2 transporter, thereby reversing multidrug resistance and restoring chemosensitivity in cancer cells to agents like topotecan. The findings highlight a promising strategy for overcoming transporter-mediated chemotherapy resistance and inform future research on combination treatments in oncology.

• Nicotine’s Role in CKD Progression: Mechanistic and Translat

  2026-07-04

  Jain and Jaimes’ review delineates how nicotine accelerates chronic kidney disease (CKD) progression by activating non-neuronal nicotinic acetylcholine receptors, enhancing oxidative stress, and promoting pro-fibrotic signaling. Their synthesis of clinical and preclinical evidence highlights actionable mechanisms that may inform new anti-lymphangiogenic and anti-fibrotic research strategies.

• FCCP: Optimizing Mitochondrial Uncoupling in HIF Pathway Stu

  2026-07-03

  FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) is a gold-standard tool for dissecting mitochondrial function, inhibition of hypoxia-inducible factor (HIF) pathways, and metabolic regulation in disease models. This article delivers a workflow-driven guide—anchored in recent literature—for maximizing data quality, troubleshooting, and experimental impact using FCCP from APExBIO.

• Origami Engineering of KR-12: Antimicrobial and Immunomodula

  2026-07-03

  This review systematically examines how structure-guided engineering of KR-12, the smallest LL-37-derived antimicrobial peptide, expands its activity spectrum, improves biofilm disruption, and enhances immune modulation. The study highlights origami-inspired modifications, nano-formulations, and immobilization strategies that boost peptide stability and efficacy against resistant pathogens, with implications for translational infection control and biomaterials applications.

• FAK Inhibitor 14 in Ovarian Cancer: Protocols and Pitfalls

  2026-07-02

  FAK Inhibitor 14 (benzene-1,2,4,5-tetraamine tetrahydrochloride) delivers high selectivity and solubility for focal adhesion kinase studies, enabling advanced modeling of the FAK/Src/COL5A1 axis in cancer biology. This article details actionable workflow enhancements, troubleshooting strategies, and unique insights informed by recent cholesterol-resistance ovarian cancer research.

• CLK2 Inhibition and Alternative Splicing: Next-Gen Translati

  2026-07-02

  Explore how TG003, a potent Cdc2-like kinase (Clk) inhibitor, is driving a paradigm shift in alternative splicing modulation and resistance research. This article unpacks the molecular rationale for targeting CLK2 in platinum-resistant ovarian cancer, synthesizes emerging evidence, and offers strategic guidance for translational scientists seeking to design robust, mechanism-driven experiments. We connect the dots between splicing regulation, chemoresistance, and therapeutic innovation—moving decisively beyond standard product summaries.

• ERK5 and MEK1/2 Roles in Vitamin D3-Induced Myeloid Differen

  2026-07-01

  This study demonstrates that the ERK5/MAPK pathway is a key mediator of 1α,25-dihydroxyvitamin D3-induced terminal differentiation in myeloid leukemia cells, operating distinctly from the canonical MEK1/2-ERK1/2 axis. The findings clarify pathway-specific effects on cell cycle and differentiation, informing strategies for combinatorial therapies in acute myeloid leukemia.

• Cyclic Pifithrin-α Hydrobromide: Advanced p53 Inhibition and

  2026-07-01

  Explore how Cyclic Pifithrin-α hydrobromide enables precision p53 inhibition in apoptosis and DNA damage response research. This in-depth guide uniquely bridges molecular mechanism, protocol optimization, and translational implications for cancer and neuroinflammatory models.

• Sulfo-Cy5 Carboxylic Acid: Precision Fluorescent Dye for Lif

  2026-06-30

  Sulfo-Cy5 carboxylic acid empowers life science researchers with robust, highly soluble fluorescent labeling—crucial for imaging workflows where reproducibility and signal clarity matter most. Its minimized quenching and compatibility with advanced nano-adjuvant immunology unlock new frontiers in protein, peptide, and immune cell tracking.

• Perifosine (KRX-0401): Advanced Applications in Apoptosis an

  2026-06-30

  Explore Perifosine (KRX-0401), a potent Akt pathway inhibitor, with an in-depth analysis of its mechanistic role in apoptosis and unique research applications. This article provides new insights beyond existing content, highlighting Perifosine’s differentiation in oncology and cell signaling studies.

• Modeling Stroma-Driven Chemoresistance in Pancreatic Cancer

  2026-06-29

  Schuth et al. developed a patient-specific 3D organoid-fibroblast co-culture system to dissect the role of cancer-associated fibroblasts (CAFs) in pancreatic ductal adenocarcinoma (PDAC) chemoresistance. Their findings reveal how stromal-tumor interactions, particularly the induction of epithelial-to-mesenchymal transition (EMT), modulate drug response, informing more precise preclinical models and therapeutic strategies.

450 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page